RNA Epitranscriptome: Role of the 5' Cap

Genetic Engineering & Biotechnology NewsVol. 39, No. 5 Drug Discovery TutorialRNA Epitranscriptome: Role of the 5' CapProducing superior mRNA therapeutics through optimized cappingAnton P. McCaffrey, PhDAnton P. McCaffrey, PhDAnton P. McCaffrey, PhD (E-mail Address: amccaffrey@trilinkbiotech.com), is senior director of emerging science and innovation at TriLink BioTechnologies. www.trilinkbiotech.com.Search for more papers by this authorPublished Online:27 Apr 2019https://doi.org/10.1089/gen.39.05.17AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetailsCited bymRNA Aşılarında Güncel Yaklaşımlar21 February 2022 | Veteriner Farmakoloji ve Toksikoloji Derneği BülteniAn overview of rational design of mRNA-based therapeutics and vaccines19 July 2021 | Expert Opinion on Drug Discovery, Vol. 16, No. 11Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: Getting the message acrossAdvanced Drug Delivery Reviews, Vol. 176Self-amplifying RNA vaccines for infectious diseases22 October 2020 | Gene Therapy, Vol. 28, No. 3-4 Volume 39Issue 5May 2019 InformationCopyright © GEN PublishingTo cite this article:Anton P. McCaffrey, PhD.RNA Epitranscriptome: Role of the 5' Cap.Genetic Engineering & Biotechnology News.May 2019.59, 61.http://doi.org/10.1089/gen.39.05.17Published in Volume: 39 Issue 5: April 27, 2019PDF download